Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Biopharma incumbents (Novo Nordisk, Lilly, Pfizer, Roche) and dozens of startups are racing to capture slices of this multibillion-dollar obesity opportunity
Trial FLOW (Perkovic et al., NEJM 2024) Design Phase 3 / event-driven Population 3,533 adults with T2D and CKD Key result 24% reduction in kidney disease progression and CV death (HR 0.76
Be sure to talk to your medical team about your full treatment plan, as this will involve more than just medicines
All medications arrive with clear expiration dating and stability information
US$ 25.18
US$ 23.85
US$ 21.18
US$ 23.35
US$ 20.81
US$ 20.65
US$ 29.18
US$ 29.35
US$ 25.08
